Gastroparesis Market 2027 by Gastroparesis Type, Drug Class Type, Distribution Channel and Geography | The Insight Partners

Gastroparesis Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Gastroparesis Type ( Idiopathic, Diabetic, Post-Surgical, Others ); Drug Class Type ( Prokinetic Agents, Botulinum Toxin Injection, Antiemetic Agents ); Distribution Channel ( Retail Pharmacies, Hospital Pharmacies, Others ) and Geography

Report Code: TIPRE00008992 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Gastroparesis is a condition that affects the normal spontaneous movement of the muscles (motility) in your stomach. Gastroparesis can interfere with normal digestion, cause nausea and vomiting, and cause problems with blood sugar levels and nutrition.

MARKET DYNAMICS

Increase in prevalence of diabetes mellitus among people, as approximately 5 to 10% of insulin-dependent diabetics may progress to severe symptomatic gastroparesis. Moreover, rising incidences of gastroparesis, for instance, as per Swinburne University of Technology, more than 1.5 million Americans suffer from severe gastroparesis, and approximately 120,000 Australians are affected by the disorder. However, usage of OTC drugs, side effects of available gastroparesis drugs in future will impede the market growth.

MARKET SCOPE
`
The "Global Gastroparesis Market analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Gastroparesis Market with detailed market segmentation by gastroparesis type, drug class type, distribution channel, end-use and geography. The Global Gastroparesis Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Gastroparesis Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Global Gastroparesis Market is segmented on the basis of gastroparesis type, drug class type, and distribution channel. Based on drug class type, the market has been categorized as prokinetic agents, botulinum toxin injection, and antiemetic agents. Based on gastroparesis type, the market has been categorized as idiopathic, diabetic, post-surgical, others. Based on distribution channel, the Gastroparesis market has been classified into retail pharmacies, hospital pharmacies, and others.?

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Gastroparesis Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Gastroparesis Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Gastroparesis Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Gastroparesis Market in these regions.



Get more information on this report :

MARKET PLAYERS

The report covers key developments in the Gastroparesis Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Gastroparesis Market are anticipated to lucrative growth opportunities in the future with the rising demand for Gastroparesis Market in the global market. Below mentioned is the list of few companies engaged in the Gastroparesis Market.

The report also includes the profiles of key Gastroparesis Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Boston Scientific Corporation
- Cardinal Health, Inc.
- C. R. Bard, Inc.
- Abbott Laboratories
- Medtronic
- Salix Pharmaceuticals, Inc.
- Janssen Global Services, LLC
- Teva Pharmaceuticals
- Kimberly-Clark Corporation
- Rhythm Pharmaceuticals, Inc.
- Alfa Wassermann SPA
- Evoke Pharma

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Gastroparesis Market - By Gastroparesis Type
1.3.2 Gastroparesis Market - By Drug Class Type
1.3.3 Gastroparesis Market - By Distribution Channel
1.3.4 Gastroparesis Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GASTROPARESIS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GASTROPARESIS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. GASTROPARESIS MARKET - GLOBAL MARKET ANALYSIS
6.1. GASTROPARESIS - GLOBAL MARKET OVERVIEW
6.2. GASTROPARESIS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. GASTROPARESIS MARKET - REVENUE AND FORECASTS TO 2027 - GASTROPARESIS TYPE
7.1. OVERVIEW
7.2. GASTROPARESIS TYPE MARKET FORECASTS AND ANALYSIS
7.3. IDIOPATHIC
7.3.1. Overview
7.3.2. Idiopathic Market Forecast and Analysis
7.4. DIABETIC
7.4.1. Overview
7.4.2. Diabetic Market Forecast and Analysis
7.5. POST-SURGICAL
7.5.1. Overview
7.5.2. Post-Surgical Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. GASTROPARESIS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS TYPE
8.1. OVERVIEW
8.2. DRUG CLASS TYPE MARKET FORECASTS AND ANALYSIS
8.3. PROKINETIC AGENTS
8.3.1. Overview
8.3.2. Prokinetic Agents Market Forecast and Analysis
8.4. BOTULINUM TOXIN INJECTION
8.4.1. Overview
8.4.2. Botulinum Toxin Injection Market Forecast and Analysis
8.5. ANTIEMETIC AGENTS
8.5.1. Overview
8.5.2. Antiemetic Agents Market Forecast and Analysis
9. GASTROPARESIS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. RETAIL PHARMACIES
9.3.1. Overview
9.3.2. Retail Pharmacies Market Forecast and Analysis
9.4. HOSPITAL PHARMACIES
9.4.1. Overview
9.4.2. Hospital Pharmacies Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. GASTROPARESIS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Gastroparesis Market Overview
10.1.2 North America Gastroparesis Market Forecasts and Analysis
10.1.3 North America Gastroparesis Market Forecasts and Analysis - By Gastroparesis Type
10.1.4 North America Gastroparesis Market Forecasts and Analysis - By Drug Class Type
10.1.5 North America Gastroparesis Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Gastroparesis Market Forecasts and Analysis - By Countries
10.1.6.1 United States Gastroparesis Market
10.1.6.1.1 United States Gastroparesis Market by Gastroparesis Type
10.1.6.1.2 United States Gastroparesis Market by Drug Class Type
10.1.6.1.3 United States Gastroparesis Market by Distribution Channel
10.1.6.2 Canada Gastroparesis Market
10.1.6.2.1 Canada Gastroparesis Market by Gastroparesis Type
10.1.6.2.2 Canada Gastroparesis Market by Drug Class Type
10.1.6.2.3 Canada Gastroparesis Market by Distribution Channel
10.1.6.3 Mexico Gastroparesis Market
10.1.6.3.1 Mexico Gastroparesis Market by Gastroparesis Type
10.1.6.3.2 Mexico Gastroparesis Market by Drug Class Type
10.1.6.3.3 Mexico Gastroparesis Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Gastroparesis Market Overview
10.2.2 Europe Gastroparesis Market Forecasts and Analysis
10.2.3 Europe Gastroparesis Market Forecasts and Analysis - By Gastroparesis Type
10.2.4 Europe Gastroparesis Market Forecasts and Analysis - By Drug Class Type
10.2.5 Europe Gastroparesis Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Gastroparesis Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Gastroparesis Market
10.2.6.1.1 Germany Gastroparesis Market by Gastroparesis Type
10.2.6.1.2 Germany Gastroparesis Market by Drug Class Type
10.2.6.1.3 Germany Gastroparesis Market by Distribution Channel
10.2.6.2 France Gastroparesis Market
10.2.6.2.1 France Gastroparesis Market by Gastroparesis Type
10.2.6.2.2 France Gastroparesis Market by Drug Class Type
10.2.6.2.3 France Gastroparesis Market by Distribution Channel
10.2.6.3 Italy Gastroparesis Market
10.2.6.3.1 Italy Gastroparesis Market by Gastroparesis Type
10.2.6.3.2 Italy Gastroparesis Market by Drug Class Type
10.2.6.3.3 Italy Gastroparesis Market by Distribution Channel
10.2.6.4 Spain Gastroparesis Market
10.2.6.4.1 Spain Gastroparesis Market by Gastroparesis Type
10.2.6.4.2 Spain Gastroparesis Market by Drug Class Type
10.2.6.4.3 Spain Gastroparesis Market by Distribution Channel
10.2.6.5 United Kingdom Gastroparesis Market
10.2.6.5.1 United Kingdom Gastroparesis Market by Gastroparesis Type
10.2.6.5.2 United Kingdom Gastroparesis Market by Drug Class Type
10.2.6.5.3 United Kingdom Gastroparesis Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Gastroparesis Market Overview
10.3.2 Asia-Pacific Gastroparesis Market Forecasts and Analysis
10.3.3 Asia-Pacific Gastroparesis Market Forecasts and Analysis - By Gastroparesis Type
10.3.4 Asia-Pacific Gastroparesis Market Forecasts and Analysis - By Drug Class Type
10.3.5 Asia-Pacific Gastroparesis Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Gastroparesis Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Gastroparesis Market
10.3.6.1.1 Australia Gastroparesis Market by Gastroparesis Type
10.3.6.1.2 Australia Gastroparesis Market by Drug Class Type
10.3.6.1.3 Australia Gastroparesis Market by Distribution Channel
10.3.6.2 China Gastroparesis Market
10.3.6.2.1 China Gastroparesis Market by Gastroparesis Type
10.3.6.2.2 China Gastroparesis Market by Drug Class Type
10.3.6.2.3 China Gastroparesis Market by Distribution Channel
10.3.6.3 India Gastroparesis Market
10.3.6.3.1 India Gastroparesis Market by Gastroparesis Type
10.3.6.3.2 India Gastroparesis Market by Drug Class Type
10.3.6.3.3 India Gastroparesis Market by Distribution Channel
10.3.6.4 Japan Gastroparesis Market
10.3.6.4.1 Japan Gastroparesis Market by Gastroparesis Type
10.3.6.4.2 Japan Gastroparesis Market by Drug Class Type
10.3.6.4.3 Japan Gastroparesis Market by Distribution Channel
10.3.6.5 South Korea Gastroparesis Market
10.3.6.5.1 South Korea Gastroparesis Market by Gastroparesis Type
10.3.6.5.2 South Korea Gastroparesis Market by Drug Class Type
10.3.6.5.3 South Korea Gastroparesis Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Gastroparesis Market Overview
10.4.2 Middle East and Africa Gastroparesis Market Forecasts and Analysis
10.4.3 Middle East and Africa Gastroparesis Market Forecasts and Analysis - By Gastroparesis Type
10.4.4 Middle East and Africa Gastroparesis Market Forecasts and Analysis - By Drug Class Type
10.4.5 Middle East and Africa Gastroparesis Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Gastroparesis Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Gastroparesis Market
10.4.6.1.1 South Africa Gastroparesis Market by Gastroparesis Type
10.4.6.1.2 South Africa Gastroparesis Market by Drug Class Type
10.4.6.1.3 South Africa Gastroparesis Market by Distribution Channel
10.4.6.2 Saudi Arabia Gastroparesis Market
10.4.6.2.1 Saudi Arabia Gastroparesis Market by Gastroparesis Type
10.4.6.2.2 Saudi Arabia Gastroparesis Market by Drug Class Type
10.4.6.2.3 Saudi Arabia Gastroparesis Market by Distribution Channel
10.4.6.3 U.A.E Gastroparesis Market
10.4.6.3.1 U.A.E Gastroparesis Market by Gastroparesis Type
10.4.6.3.2 U.A.E Gastroparesis Market by Drug Class Type
10.4.6.3.3 U.A.E Gastroparesis Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Gastroparesis Market Overview
10.5.2 South and Central America Gastroparesis Market Forecasts and Analysis
10.5.3 South and Central America Gastroparesis Market Forecasts and Analysis - By Gastroparesis Type
10.5.4 South and Central America Gastroparesis Market Forecasts and Analysis - By Drug Class Type
10.5.5 South and Central America Gastroparesis Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Gastroparesis Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Gastroparesis Market
10.5.6.1.1 Brazil Gastroparesis Market by Gastroparesis Type
10.5.6.1.2 Brazil Gastroparesis Market by Drug Class Type
10.5.6.1.3 Brazil Gastroparesis Market by Distribution Channel
10.5.6.2 Argentina Gastroparesis Market
10.5.6.2.1 Argentina Gastroparesis Market by Gastroparesis Type
10.5.6.2.2 Argentina Gastroparesis Market by Drug Class Type
10.5.6.2.3 Argentina Gastroparesis Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. GASTROPARESIS MARKET, KEY COMPANY PROFILES
12.1. BOSTON SCIENTIFIC CORPORATION
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CARDINAL HEALTH, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. C. R. BARD, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ABBOTT LABORATORIES
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MEDTRONIC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SALIX PHARMACEUTICALS, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.7. JANSSEN GLOBAL SERVICES,
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.8. LLCTEVA PHARMACEUTICALS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.9. KIMBERLY-CLARK
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.10. EVOKE PHARMA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Boston Scientific Corporation
2. Cardinal Health, Inc.
3. C. R. Bard, Inc.
4. Abbott Laboratories
5. Medtronic
6. Salix Pharmaceuticals, Inc.
7. Janssen Global Services, LLC
8. Teva Pharmaceuticals
9. Kimberly-Clark Corporation
10. Rhythm Pharmaceuticals, Inc.
11. Alfa Wassermann SPA
12. Evoke Pharma

TIPRE00008992
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking